
September 10, 2025 | 12:00 – 1:00 PM ET
Sponsored by: Medscape Education. Supported by an independent educational grant from Neurocrine Biosciences, Inc.
PROGRAM DESCRIPTION
Congenital adrenal hyperplasia (CAH) presents complex, lifelong challenges that impact patients’ quality of life—from growth suppression in children to long-term metabolic and psychological effects. This symposium offers clinicians a unique opportunity to build confidence in managing CAH, especially amid the emergence of innovative therapies that may reduce reliance on glucocorticoids. Gain insights into timely diagnosis, individualized treatment strategies, and optimizing care during critical transitions such as puberty and adulthood.
Join us to explore cutting-edge advances and improve outcomes for pediatric and adolescent patients living with this rare, often misunderstood condition. Empower your practice with the latest in CAH management.
Learning objectives:
Upon completion of this activity, participants will have greater competence related to:
- Use of new therapeutic approaches for managing pediatric/adolescent patients with CAH
- Comprehensive care in pediatric/adolescent patients with CAH
- Timely diagnosis and management (including intensification or adjustment to pharmacologic management) in pediatric/adolescent patients with CAH
Demonstrate greater confidence in their ability to:
- Comprehensively manage CAH in the pediatric population
CMEs will be offered.
SPEAKERS:
- Richard J. Auchus, MD, PhD, FACE
The James A. Shayman and Andrea
S. Kevrick Professor of Translational Medicine, Division of Metabolism, Endocrinology and Diabetes
Departments of Internal Medicine and Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan - Patricia Y. Fechner, MD
Professor of Pediatrics
University of Washington School of Medicine, Medical Director
Seattle Children’s CAH Center of Excellence, Seattle, Washington - Phyllis W. Speiser, MD
Emeritus Professor of Pediatrics
Zucker School of Medicine at Hofstra/Northwell
Hempstead, New York
Sponsored by Medscape Education. Supported by an independent educational grant from Neurocrine Biosciences, Inc.